4.7 Article

Long-term expression changes of immune-related genes in prostate cancer after radiotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses

Joseph Sia et al.

Summary: The study revealed that radiation dose per fraction and total dose can independently and differentially affect the immunomodulatory capacity of radiation therapy. Radiation dose per fraction had a greater impact on inducing local antitumor T cell responses, while total dose was more influential on natural killer cell-mediated control of irradiated tumors.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Article Medicine, Research & Experimental

The lncRNAs LINC00261 and LINC00665 are upregulated in long-term prostate cancer adaptation after radiotherapy

Iris Eke et al.

Summary: The study revealed that the upregulation of LINC00261 and LINC00665 long non-coding RNAs in tumors after radiotherapy may have a negative impact on the overall survival of prostate cancer patients. Knockdown of these lncRNAs affected DNA repair protein expression and microRNA levels, leading to reduced survival after reirradiation. Understanding long-term tumor adaptation mechanisms could facilitate the discovery of new molecular targets for improved multimodal radiation oncologic treatments.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Biochemistry & Molecular Biology

53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy

Iris Eke et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Oncology

CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection

Erik Wennerberg et al.

CANCER IMMUNOLOGY RESEARCH (2020)

Article Oncology

High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot

Simon P. Keam et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Oncology

Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition

Wendy Mao et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Review Oncology

Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks

Michael C. Comiskey et al.

CURRENT ONCOLOGY REPORTS (2018)

Article Biochemistry & Molecular Biology

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Silvia C. Formenti et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

Claire Vanpouille-Box et al.

NATURE COMMUNICATIONS (2017)

Review Urology & Nephrology

Optimal Treatment Sequence for Metastatic Castration-resistant Prostate Cancer

David Lorente et al.

EUROPEAN UROLOGY FOCUS (2016)

Article Biochemistry & Molecular Biology

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

Katherine B. Chiappinelli et al.

Article Oncology

Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer

Iris Eke et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Oncology

Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer

Iris Eke et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Review Oncology

Role of Local Radiation Therapy in Cancer Immunotherapy

Sandra Demaria et al.

JAMA ONCOLOGY (2015)

Article Biochemistry & Molecular Biology

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu et al.

NATURE MEDICINE (2014)

Article Immunology

Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3–5, 2011

Natalia Aptsiauri et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)

Article Oncology

Maximizing Tumor Immunity With Fractionated Radiation

Doerthe Schaue et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)

Review Immunology

The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy

Heath A. Smith et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)

Article Oncology

Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells

Craig Gedye et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)

Review Oncology

Cancer/testis (CT) antigens: Potential targets for immunotherapy

Otavia L. Caballero et al.

CANCER SCIENCE (2009)

Review Oncology

Radiation-induced cell signaling: inside-out and outside-in

Kristoffer Valerie et al.

MOLECULAR CANCER THERAPEUTICS (2007)

Review Endocrinology & Metabolism

Molecular characterization of human prostate carcinoma cell lines

A van Bokhoven et al.

PROSTATE (2003)